急性冠症候群(ACS)治療薬の世界市場2015-2019...市場調査レポートについてご紹介

【英文タイトル】Global Acute Coronary Syndrome (ACS) Market 2015-2019

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Disease Overview
06.1 Understanding the Disease
06.2 Burden of Disease
06.3 Etiology
06.4 Pathophysiology
06.4.1 Myocardial Dysfunction
06.4.2 MI
06.4.3 Electrical Dysfunction
06.5 Prognosis
06.6 Epidemiology
06.6.1 Prevalence of Coronary Artery Disease
06.7 Diagnosis
06.7.1 ECG
06.7.2 Blood Tests
06.7.3 Nuclear Scan
06.7.4 CT
06.8 Management

07.ACS Pipeline Landscape
07.1 Key Pipeline Molecules

08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis

09.Market Segmentation by ECG Output

10 Geographical Segmentation

11 Buying Criteria

12 Market Growth Drivers

13 Drivers and their Impact

14 Market Challenges

15 Impact of Drivers and Challenges

16 Market Trends

17 Trends and their Impact

18 Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 AstraZeneca
18.2.2 Bristol-Myers Squibb
18.2.3 Eli Lilly
18.2.4 GlaxoSmithKline
18.2.5 Sanofi
18.3 Other Prominent Vendors

19 Key Vendor Analysis
19.1 AstraZeneca
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation by Revenue 2013
19.1.4 Business Segmentation by Revenue 2011-2013
19.1.5 Revenue by Geography
19.1.6 Business Strategy
19.1.7 Key Developments
19.1.8 SWOT Analysis
19.2 Bristol-Myers Squibb
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Key Product Offerings
19.2.4 Revenue by Geography
19.2.5 Business Strategy
19.2.6 Key Information
19.2.7 SWOT Analysis
19.3 Eli Lilly
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue
19.3.4 Revenue by Geography
19.3.5 Business Strategy
19.3.6 Key Information
19.3.7 SWOT Analysis
19.4 GlaxoSmithKline
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation
19.4.4 Business Segmentation by Revenue 2012 and 2013
19.4.5 Revenue by Geography
19.4.6 Pipeline Products
19.4.7 Business Strategy
19.4.8 Key Information
19.4.9 SWOT Analysis
19.5 Sanofi
19.5.1 Key Facts
19.5.2 Business Description
19.5.3 Business Segmentation
19.5.4 Revenue by Business Segmentation
19.5.5 Revenue Comparison 2012 and 2013
19.5.6 Revenue by Geography
19.5.7 Business Strategy
19.5.8 Key Developments
19.5.9 SWOT Analysis

20 Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Spectrum of ACS
Exhibit 3: Overview of ACS
Exhibit 4: Pathogenesis of ACS
Exhibit 5: Hospitalized Incident Cases of ACS 2014-2019 (millions)
Exhibit 6: Epidemiologic Transition of CV Diseases
Exhibit 7: Initial Drug Therapy for ACS
Exhibit 8: Adjunctive Drug Therapy for ACS
Exhibit 9: Surgery and Other Procedures
Exhibit 10: Snapshot of Global ACS Market 2014
Exhibit 11: Global ACS Market 2014-2019 (US$ billion)
Exhibit 12: Global ACS Market Share of Branded and Generic Drugs 2014 and 2019 (in Percent)
Exhibit 13: Segmentation of Global ACS Market by ECG Output
Exhibit 14: Diagrammatic Representation of STEMI, NSTEMI, and UA
Exhibit 15: Segmentation of Global ACS Market by ECG Output 2014
Exhibit 16: Global ACS Market by Geography 2014
Exhibit 17: Drivers of Global ACS Market
Exhibit 18: Comparison of Elderly Population 2012 and 2050 (Aged 65 and Older)
Exhibit 19: Challenges in Global ACS Market
Exhibit 20: Trends in Global ACS Market
Exhibit 21: Global Revenue of AstraZeneca for CV and Metabolic Diseases 2011-2013 (US$ million)
Exhibit 22: Estimated Filings of Brilinta/Brilique
Exhibit 23: Line Extensions for Brilinta/Brilique
Exhibit 24: Global Revenue of Brilinta/Brilique by AstraZeneca 2011-2013 (US$ million)
Exhibit 25: Global Revenue of Plavix by Bristol-Myers Squibb 2010-2012 (US$ million)
Exhibit 26: Revenue of Eli Lilly by Therapeutic Area 2013
Exhibit 27: Global Revenue of Effient by Eli Lilly 2010-2013 (US$ million)
Exhibit 28: Global Revenue of Arixtra by GlaxoSmithKline 2011-2013 (US$ million)
Exhibit 29: Global Revenue of Plavix by Sanofi 2011-2013 (US$ million)
Exhibit 30: Global Revenue of Lovenox by Sanofi 2011-2013 (US$ million)
Exhibit 31: AstraZeneca plc: Business Segmentation by Revenue 2013
Exhibit 32: AstraZeneca plc: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 33: AstraZeneca: Revenue by Geography 2013
Exhibit 34: Bristol-Myers Squibb Co.: Key Product Offerings (Based on Therapeutic Areas)
Exhibit 35: Bristol-Myers Squibb Co.: Revenue by Geographical Segmentation 2013
Exhibit 36: Eli Lilly: Business Segmentation by Revenue 2013
Exhibit 37: Eli Lilly: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 38: Eli Lilly: Revenue by Geography 2013
Exhibit 39: GlaxoSmithKline: Business Segmentation 2013
Exhibit 40: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 41: GlaxoSmithKline: Revenue by Geography 2013
Exhibit 42: GlaxoSmithKline: Pipeline Products 2013
Exhibit 43: Sanofi: Business Segmentation
Exhibit 44: Sanofi: Revenue by Business Segmentation 2013
Exhibit 45: Sanofi: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 46: Sanofi: Revenue by Geographical Segmentation 2013


【レポート販売概要】

■ タイトル:急性冠症候群(ACS)治療薬の世界市場2015-2019
■ 英文:Global Acute Coronary Syndrome (ACS) Market 2015-2019
■ 発行日:2015年3月18日
■ 調査会社:Technavio
■ 商品コード:IRTNTR5471
■ 調査対象地域:グローバル
  • 世界の艦艇及び水上戦闘艦艇市場動向2013-2023:競合環境及び戦略的インサイト
    The report provides a detailed analysis of the competitive landscape of the Naval Vessels and Surface Combatants market. It provides an overview of key Naval Vessels and Surface Combatants companies catering to the Naval Vessels and Surface Combatants sector, together with insights such as key alliances, strategic initiatives and a brief financial analysis. The global surface combatant industry is …
  • エストラジオールの市場別医療検査数および販売予測
    This new report from Venture Planning Group provides analysis of Estradiol testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing   - Hospitals - Commercial/Private Laboratories P …
  • 消費者用ネットワークアタッチトストレージ(NAS)の世界市場分析
    The global consumer NAS market is expected to reach USD 8.20 billion by 2025, according to a new report by Grand View Research, Inc. Globally growing demand for efficient data backup systems, speedy data transfer, and cost-effective storage systems are some of the key drivers for the consumer network attached storage market. Home segment is one of the largest segment in 2016 and is expected to mai …
  • フルオロケイ酸の世界市場2019-2023
    Global Fluorosilicic Acid Market: About this market Technavio’s fluorosilicic acid market analysis considers sales from water fluoridation, chemical manufacturing, metal surface treatment, and electroplating, hide processing, and others. Our analysis also considers the sales of fluorosilicic acid in APAC, Europe, North America, South America, and MEA. In 2018, the water fluoridation segment had a …
  • 3Dセンサの世界市場:画像センサ、ポジションセンサ、音響センサ、加速度センサ
    The 3D sensormarket report analyzes the ecosystem of the 3D sensor technology; and the market segmented on the basis oftechnology includesstereo vision, structured light, time of flight, and ultra sound. The report also provides the geographic view for the major regions,namely,North America, Europe, Asia-Pacific (APAC), and the Rest of the World (RoW). It also discusses the burning issues, market …
  • グローバルにおける空気圧モーターおよびエンジン市場(~2019)
    The industry report Global Pneumatic Power Motor and Engine Market to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for pneumatic power motors and engines in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for indu …
  • 伝染性下痢(Infectious Diarrhea):世界の治験レビュー(2015年上半期版)
    Infectious Diarrhea Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Infectious Diarrhea Global Clinical Trials Review, H1, 2015" provides data on the Infectitious Diarrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Infectitious Diarrhea . It includes an overview of the trial numbers and their …
  • Crew Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013
    Crew Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Crew Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
  • 世界の鉄道管理システム市場動向(2014-2019)
    The traffic complexities on the roadways are posing a major challenge in the field of ground transportation. While the rising aviation fuel costs have made air-travel an expensive affair, rail transportation could be a feasible ground transport solution to the infrastructure saturation in developed and developing economies. Rail transportation can provide a safer, more reliable, and cost-competiti …
  • カナダのバイオ燃料市場分析:Analyzing the Biofuels Market in Canada
    Although biofuels are mainly used to replace or supplement the traditional petroleum-based transportation fuels, they can also be deployed to generate heat and electricity. Being an alternative to fossils, biofuels can be applied to existing vehicles with little or no engine modification. Although they release CO2 when burned in internal combustion engines, they differ from fossil fuels partly bec …
  • モバイルヘルス(mHealth)の世界市場予測2015-2020
    The advent of connected devices and M2M is offering a tremendous opportunity for healthcare professionals. Near-ubiquitous mobile networks are allowing carers to diagnose, monitor, and communicate with patients with unprecedented speed and efficacy. The emergence of low-cost smartphones has allowed wider access to app stores, which are now home to over 100,000 unique mHealth apps. These range betw …
  • 止血(Hemostasis):世界の治験レビュー(2015年上半期版)
    Hemostasis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H1, 2015" provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across t …
  • BIPVの世界市場分析:技術別(結晶シリコン、薄膜)、用途別(屋根、壁、ガラス統合、ファサード)、エンドユーザー別(住居用、商業用、産業用)、地域別(北アメリカ、ヨーロッパ、アジア太平洋)、セグメント予測、2013 – 2024
    The global BIPV and BIOPV market size is expected to reach USD 31.14 billion by 2024, according to a new report by Grand View Research, Inc. Rising adoption of energy generation by renewable sources without comprising on the aesthetic appeal of buildings is expected to drive growth over the forecast period. Increasing demand for integrated installations is expected to be driven by the growing disp …
  • 映像監視製品の世界市場:アナログカメラ、IPカメラ、DVR、ビデオエンコーダ、監視ソフトウェア、NVR
    Technavios research analyst predicts the global video surveillance market to grow steadily at a CAGR of over 22% during the forecast period. The increasing demand for wireless network infrastructure is the key growth driver for this market. Video surveillance solutions incur high network deployment cost and maintenance cost. Enterprises are opting for wireless network infrastructure to avoid these …
  • 神経因性疼痛(Neuropathic Pain):グローバル治療薬予測と市場分析
    PharmaPoint: Neuropathic Pain - Global Drug Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive pain, which is a consequence of trauma, injury, or inflammation. The main difference between neuropathic and nociceptive pain is the absence of a continuous nociceptive input in neuropathic pa …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。